Corporate Citizenship

For more than 130 years, Eli Lilly and Company ("Lilly") has sought to earn the public's trust by upholding the highest standards in the way we make medicines, conduct business and act as a corporate citizen.

In this part of our website, you will find our 2006/07 Corporate Citizenship Report, which summarizes our economic, social and environmental performance and outlines important issues facing our industry and our responses to them. Other information relevant to corporate citizenship at Lilly can be found in the "about" and "investors" sections of this website, and in our previous corporate citizenship reports, available below.

A 77-page PDF report "Providing Value to Patients and Society" is aligned with the Global Reporting Initiative (GRI) Guidelines issued in October 2006, at the B application level. An index to the GRI indicators is found at the end of the full report. More information about GRI and the application levels can be found at www.globalreporting.org.

Downloads available:

Complete Report (3,855KB)

Executive Summary (636KB)

Includes:

Clinical Trial Registry

Grants Registry

Report of Political Financial Support

Links to past reports:

2005/06 Corporate Citizenship Report (PDF) (1,200KB)

2004/05 Corporate Citizenship Report (PDF) (1,200KB)